B. Valenza

485 total citations
10 papers, 91 citations indexed

About

B. Valenza is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, B. Valenza has authored 10 papers receiving a total of 91 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in B. Valenza's work include Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (3 papers) and Prostate Cancer Treatment and Research (3 papers). B. Valenza is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (3 papers) and Prostate Cancer Treatment and Research (3 papers). B. Valenza collaborates with scholars based in France, Belgium and Switzerland. B. Valenza's co-authors include D. Serin, Michel Fabbro, Franck Priou, Pascal Piedbois, Jean François Berdah, É. Teissier, Cyril Foa, Frédéric Peyrade, Philippe Ronchin and D. Chevallier and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and British Journal of Urology.

In The Last Decade

B. Valenza

8 papers receiving 86 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Valenza France 6 67 34 31 11 10 10 91
Yan-Song Liu China 4 103 1.5× 28 0.8× 37 1.2× 6 0.5× 5 0.5× 6 111
Sucheta More India 6 69 1.0× 99 2.9× 34 1.1× 7 0.6× 8 0.8× 24 141
Serena Corsetti Italy 8 55 0.8× 34 1.0× 25 0.8× 3 0.3× 5 0.5× 19 112
Donatella Grasso Italy 9 107 1.6× 40 1.2× 25 0.8× 20 1.8× 20 2.0× 22 159
Kristiina Ojamaa Estonia 4 91 1.4× 57 1.7× 22 0.7× 2 0.2× 8 0.8× 9 125
Dahlia Henry United States 5 65 1.0× 49 1.4× 16 0.5× 9 0.8× 4 0.4× 7 115
Fernando Palacios Salas Peru 6 156 2.3× 51 1.5× 76 2.5× 6 0.5× 3 0.3× 18 194
Timothy F. Goggins United States 7 50 0.7× 21 0.6× 11 0.4× 21 1.9× 4 0.4× 12 89
Miguel Pastor Borgoñón Spain 8 57 0.9× 30 0.9× 21 0.7× 10 0.9× 5 0.5× 13 144
Judith Fraser United Kingdom 5 54 0.8× 15 0.4× 21 0.7× 3 0.3× 4 0.4× 11 70

Countries citing papers authored by B. Valenza

Since Specialization
Citations

This map shows the geographic impact of B. Valenza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Valenza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Valenza more than expected).

Fields of papers citing papers by B. Valenza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Valenza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Valenza. The network helps show where B. Valenza may publish in the future.

Co-authorship network of co-authors of B. Valenza

This figure shows the co-authorship network connecting the top 25 collaborators of B. Valenza. A scholar is included among the top collaborators of B. Valenza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Valenza. B. Valenza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Aparicio, Thomas, Faïza Khemissa, Pascal Artru, et al.. (2018). Phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients (pts) over 70 with previously treated metastatic colorectal adenocarcinoma (mCRC) FFCD 1404 - REGOLD. Annals of Oncology. 29. viii156–viii156. 2 indexed citations
3.
Joly, Florence, R. Delva, Loı̈c Mourey, et al.. (2013). Clinical benefits of non‐taxane chemotherapies in unselected patients with symptomatic metastatic castration‐resistant prostate cancer after docetaxel: the GETUG‐P02 study. British Journal of Urology. 115(1). 65–73. 5 indexed citations
4.
Largillier, R., B. Valenza, J-M Ferrero, et al.. (2007). Haematological Evaluation of Weekly Therapy with Topotecan for the Treatment of Recurrent Ovarian Cancer Resistant to Platinum-Based Therapy. Oncology. 73(3-4). 177–184. 11 indexed citations
5.
6.
Piedbois, Pascal, D. Serin, Franck Priou, et al.. (2005). AERO-B03: A randomized phase II trial of dose-dense docetaxel in node-positive breast cancer. Journal of Clinical Oncology. 23(16_suppl). 647–647. 2 indexed citations
7.
Ferrero, Jean-­Marc, Cyril Foa, Simon Thézenas, et al.. (2004). A Weekly Schedule of Docetaxel for Metastatic Hormone-Refractory Prostate Cancer. Oncology. 66(4). 281–287. 28 indexed citations
8.
Cals, L., et al.. (2004). Weekly Combination of Docetaxel and Vinorelbine in Metastatic Breast Cancer: A Phase I/II Study. Oncology. 67(3-4). 257–261. 6 indexed citations
9.
Ferrero, J-M, Cyril Foa, Simon Thézenas, et al.. (2003). A phase II of weekly docetaxel for hormone refractory metastatic prostate cancer (HRMPC). European Urology Supplements. 2(1). 24–24. 1 indexed citations
10.
Marcy, Pierre‐Yves, et al.. (2002). [Brachial fluoroscopically guided implantation of venous port devices in oncology patients].. PubMed. 89(7-8). 707–12. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan-Song Liu Breakdown of academic impact, for papers by Sucheta More Breakdown of academic impact, for papers by Serena Corsetti Breakdown of academic impact, for papers by Donatella Grasso Breakdown of academic impact, for papers by Kristiina Ojamaa Breakdown of academic impact, for papers by Dahlia Henry Breakdown of academic impact, for papers by Fernando Palacios Salas Breakdown of academic impact, for papers by Timothy F. Goggins Breakdown of academic impact, for papers by Miguel Pastor Borgoñón Breakdown of academic impact, for papers by Judith Fraser
Rankless by CCL
2026